Awareness for “Growth Factors” in India: A social initiative of Intas Biopharmaceuticals Limited

Cancer, being one of the most dreadful diseases in recent times, has generated a necessity to increase the awareness in the society and medical fraternity. The Oncology market in India has witnessed sharp growth in recent years and it has become a requisite for dedicated Oncology companies like Intas Biopharmaceuticals Limited (IBPL) to play a leading role in increasing the awareness of scientific knowledge and information related to Research & Development of Cancer in the community.

For the last two decades, Growth Factors have been increasingly used in the treatment of Hematologic and Oncologic diseases like Neutropenia, Myelodysplastic Syndrome (MDS), Leukemias, Aplastic Anaemia and Bone Marrow Transplantation. Commenting on the social initiative, MR. SIMON DANIEL, Chief Executive (Marketing), Intas Biopharmaceuticals Limited, said, “There is a growing need to dissipate and inform medical fraternity and the community, at large about Growth Factors. It, so far, is an ideal treatment for haematological disorders. As much as 20 international symposiums on Growth Factors were organized in past six months by IBPL that witnessed participation of leading Oncologists and Cancer Specialists across the country.
As a company, which is respected as a scientifically driven organization, IBPL is committed to channelize its efforts towards dissipating technical information and through symposiums.”

Through such social initiatives, in past few months, Intas Biopharmaceuticals Limited has built a very strong scientific image in the medical fraternity across the country. The recently concluded international symposiums on Growth Factors witnessed participation of more than 200 leading Cancer Specialists from across the country, which is indicative of IBPL’s commitment to engage medical fraternity in spreading the Oncology awareness. In the month of August along, as many as 10 symposiums were organized across the country. A series of symposiums and clinical meetings in the past few months has seen a change in the perception of organization.

Intas Biopharmaceuticals Limited is one of the fastest growing Oncology Company in India and such scientific programs and symposiums will further prepare the company to be the most coveted one.

About Intas Biopharmaceuticals Limited:
Intas Biopharmaceuticals Limited (IBPL) has fully integrated oncology operations at Ahmedabad, Gujarat. Since the launch of its operations in May 2000, the company has maintained a special focus on Oncology (Cancer). IBPL has carved a niche in the biopharmaceutical operations with the one–of-its-kind of manufacturing facility in India certified by European Agency for the Evaluation of Medicinal Products (EMEA) for one of its lead product. In terms of quality standards, the facility complies with strict international Good Manufacturing Practice regulations and conforms to guidelines laid down by World Health Organization (WHO).

Intas Biopharmaceuticals Limited
Plot No. 423/P/A/GIDC, Sarkhej-Bavla Highway
Moraiya, Tal: Sanand, Ahmedabad – 382 210 INDIA
Tel: (02717) – 660100/660101; Fax: (02717) – 251189

For Media queries, contact:
Siddharth J. Baad
siddharth.baad@intasbiopharma.co.in

This release was published on openPR.